Objective: Our first objective was to report our experience on robot-assisted vesico-vaginal fistula (VVF) repair after radical surgery for gynecologic malignancies without omental flap interposition using a da Vinci robotic system. The second objective was to critically review the literature in order to analyze surgical solutions used to avoid repair failure. Materials and Methods: Five patients with VVF diagnosed after previous open surgery for gynecologic malignancies referred to our tertiary institutions were selected. After an adequate oncologic follow-up, based on the fistula diameter and conservative management failure, robotic surgery repair was proposed. A bivalve 2-layer suturing technique was carried out without tissue interpositions; omentum was not available secondary to previous surgery including hysterectomy, ovaryectomy, and omentectomy and citoreductive peritoneomectomy. A systematic review of the literature was performed in December 2016 using the PubMed database with the following keywords: robotic, robot-assisted, vesico-vaginal, fistula repair. Results: Median age was 62 years (range 55-71) bearing long-lasting VVF were referred to our divisions. Median fistula diameter was 5 mm (range 3-8 mm). Fistula site was the trigone and identified during cystoscopy near the mid-line, left, and right urether meatus, respectively. The median overall and console operatory time were 250 and 120 min, respectively. Blood loss was insignificant (median 40 mL) and the median length of stay was 7 days without any complication. Ten papers were found fulfilling the mentioned criteria, from which 6 were case reports, single or multiple, accounting for the overall 41 robotic-approach-operated patients. Conclusion: The quality of the dissection and suture associated with efficient urine drainage are in our opinion the key elements of the success of our technique, which can be performed even without omentum or other tissue flap or graft interposition.

Keywords:
Robot-assisted, Surgical technique, Fistula, Vesico-vaginal, Review, Omentum, Endourology, Genitourinary reconstruction, Surgical repair
1.
Harris WJ: Early complications of abdominal and vaginal hysterectomy. Obstet Gynecol Surv 1995;50:795-805.
2.
Health Quality Ontario: Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis. Ont Health Technol Assess Ser 2010;10:1-118.
3.
Bouquet de Joliniere J, Librino A, Dubuisson JB, Khomsi F, Ben Ali N, Fadhlaoui A, et al: Robotic surgery in gynecology. Front Surg 2016;3:26.
4.
Merseburger AS, Herrmann TR, Shariat SF, Kyriazis I, Nagele U, Traxer O, et al: EAU guidelines on robotic and single-site surgery in urology. Eur Urol 2013;64:277-291.
5.
Miklos JR, Moore RD, Chinthakanan O: Laparoscopic and robotic-assisted vesicovaginal fistula repair: a systematic review of the literature. J Minim Invasive Gynecol 2015;22:727-736.
6.
Park JY, Seo SS, Kang S, Lee KB, Lim SY, Choi HS, et al: The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns. Gynecol Oncol 2006;103:977-984.
7.
Melamud O, Eichel L, Turbow B, Shanberg A: Laparoscopic vesicovaginal fistula repair with robotic reconstruction. Urology 2005;65:163-166.
8.
Sundaram BM, Kalidasan G, Hemal AK: Robotic repair of vesicovaginal fistula: case series of five patients. Urology 2006;67:970-973.
9.
Schimpf MO, Morgenstern JH, Tulikangas PK, Wagner JR: Vesicovaginal fistula repair without intentional cystotomy using the laparoscopic robotic approach: a case report. JSLS 2007;11:378-380.
10.
Hemal AK, Sharma N, Mukherjee S: Robotic repair of complex vesicouterine fistula with and without hysterectomy. Urol Int 2009;82:411-415.
11.
Gupta NP, Mishra S, Hemal AK, Mishra A, Seth A, Dogra PN: Comparative analysis of outcome between open and robotic surgical repair of recurrent supra-trigonal vesico-vaginal fistula. J Endourol 2010;24:1779-1782.
12.
Kurz M, Horstmann M, John H: Robot-assisted laparoscopic repair of high vesicovaginal fistulae with peritoneal flap inlay. Eur Urol 2012;61:229-230.
13.
Dutto L, O'Reilly B: Robotic repair of vesico-vaginal fistula with perisigmoid fat flap interposition: state of the art for a challenging case? Int Urogynecol J 2013;24:2029-2030.
14.
Bragayrac LA, Azhar RA, Fernandez G, Cabrera M, Saenz E, Machuca V, et al: Robotic repair of vesicovaginal fistulae with the transperitoneal-transvaginal approach: a case series. Int Braz J Urol 2014;40:810-815.
15.
Gellhaus PT, Bhandari A, Monn MF, Gardner TA, Kanagarajah P, Reilly CE, et al: Robotic management of genitourinary injuries from obstetric and gynaecological operations: a multi-institutional report of outcomes. BJU Int 2015;115:430-436.
16.
Price DT, Price TC: Robotic repair of a vesicovaginal fistula in an irradiated field using a dehydrated amniotic allograft as an interposition patch. J Robot Surg 2016;10:77-80.
17.
Patel VR, Thaly R, Shah K: Robotic radical prostatectomy: outcomes of 500 cases. BJU Int 2007;99:1109-1112.
18.
Fu Q, Bian W, Lv J: Bulbocavernosus muscle flap for the repair of vesicovaginal fistula. Anatomic study and clinical results. Urol Int 2009;82:416-419.
19.
Miklos JR, Moore RD: Failed omental flap vesicovaginal fistula repair subsequently repaired laparoscopically without an omental flap. Female Pelvic Med Reconstr Surg 2012;18:372-373.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.